We are a team of passionate scientists, doctors and clinicians, driven to bringing promising therapies to light.

ABOUT ANVIRON

About our company, our mission and our team.

OUR PIPELINE

Overview of our pipeline and our science

LATEST NEWS

Latest news releases and investor packages 

We are a growing team of scientists, clinicians, and physicians focused on developing promising therapies for difficult to treat diseases. Join a team that is committed to discovering and providing good medicines that make a difference in peoples lives. 

JOIN OUR TEAM

COMMUNICATIONS

Get regular updates on our company and pipeline

Thanks for submitting!

OUR DRUG PIPELINE

Our pipeline consists of two promising orphan disease therapies that have demonstrated effectivity in vitro and in vivo.    

ANV120 for

Inflammation & Autoimmune

A potent stimulator of Fc specific natural regulatory T-Cells resulting in a promising non-steroidal, non-immunosuppresive therapy to treat inflammatory and autoimmune conditions 

ANV221 for Pancreatic Cancer

A novel DPAGT-1 inhibitor shown to be superior over existing therapies at reducing pancreatic cancer tumor size and metastases in vivo models.